uniQure to Announce Second Quarter 2025 Financial Results

Core Viewpoint - uniQure N.V. is set to report its second quarter 2025 financial results on July 29, 2025, and will host a conference call to discuss these results [1]. Company Overview - uniQure is a leading gene therapy company focused on developing transformative therapies for patients with severe medical needs, including a pipeline for treating Huntington's disease, refractory temporal lobe epilepsy, ALS, Fabry disease, and other severe diseases [3]. - The company achieved a significant milestone with the approval of its gene therapy for hemophilia B, marking a historic achievement in genomic medicine after over a decade of research and clinical development [3]. Event Details - The earnings call will be available via webcast on uniQure's website, with a replay archived for 90 days [2]. - Participants wishing to join by phone must register online to receive dial-in details and a personal PIN number [2].